Skip to search formSkip to main contentSkip to account menu

Octreotide 1 MG/ML Injectable Solution

Known as: octreotide acetate 1000 ug in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Octreotide Acetate], OCTREOTIDE ACETATE 1000 ug in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Octreotide], OCTREOTIDE ACETATE 1000 ug in 1 mL SUBCUTANEOUS INJECTION, SOLUTION 
National Institutes of Health

Related topics

Related topics

22 relations
1 ML Octreotide 0.1 MG/ML InjectionAcetic AcidAcromegalyAdenoma

Broader (4)

AntidiarrhealsAntineoplastic AgentsOctreotideOctreotide Acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Diagnostic Computed Tomography Coregistration With In-111-DTPA-Octreotide Single Photon Emission Tomography/Low-Dose Computed Tomography
Objectives In-111-DTPA-octreotide (OctreoScan) is still pivotal for neuroendocrine tumor imaging, despite the introduction of Ga… 
2016
2016
Clinical Efficacy of PET/CT Using 68Ga-DOTATOC for Diagnostic Imaging
Positron emission tomography/computed tomography (PET/CT) using 68Ga-labelled DOTA0-Tyr3 octreotide (DOTATOC) is one of the… 
2015
2015
Octreotide Long-Acting Repeatable among Elderly Patients with Neuroendocrine Tumors: A Survival Analysis of SEER-Medicare Data
Background: Octreotide long-acting repeatable (LAR) is approved in the United States for the management of carcinoid syndromes… 
2008
2008
A synthetic method for peptide-PEG-lipid conjugates: application of octreotide-PEG-DSPE synthesis.
2005
2005
Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings.
Thirteen (13) patients with liver neuroendocrine carcinomas metastases, positive for somatostatin receptors, confirmed by… 
2005
2005
Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: An open-label, multicenter, non-comparative study
The aim of the present multicentric, open-label, non-comparative study was to evaluate the role of octreotide long-acting… 
2002
2002
Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer.
UNLABELLED Noninvasive monitoring of gene transfer will benefit basic research and patient care. Most gene-transfer imaging… 
2000
2000
Long-Acting Octreotide LAR Compared with Lanreotide SR in the Treatment of Acromegaly
The use of somatostatin analogues for the treatment of acromegaly is now well established. Recently long-acting preparations of… 
1999
1999
Untersuchungen zum Somatostatinrezeptor-Status bei nicht-medullären Schilddrüsenkarzinomen
Zusammenfassung Ziel: In aktuellen ln-vitro- und In-vivo-Untersuchungen wurde eine Somatostatinrezeptor-Expression bei einigen… 
1999
1999
Targeting strategies for cancer radiotherapy.
Novel strategies to increase the therapeutic ratio in clinical radioimmunotherapy studies are needed. Limitations to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)